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Individual or combined SIRS criteria may not be equivalent or interchangeable. In a study of: 
more than 130,00 patients with infection and organ failure, different individual and 
combinations of SIRS criteria were associated with marked differences in mortality. These 
differences remained unchanged after adjustment and over time and imply that individual 

















Purpose: Despite the recent Sepsis-3 consensus, the Systemic Inflammatory Response 
Syndrome (SIRS) criteria continue to be assessed and recommended. Such use implies 
equivalence and interchangeability of criteria. Thus, we aimed to test whether such criteria 
are indeed equivalent and interchangeable. 
Materials and Methods: From 2000 to 2015, we identified patients with infection, organ 
failure, and at least one SIRS criterion in 179 Intensive Care Units in Australia and New 
Zealand. We studied the association of different SIRS criteria with hospital mortality. 
Results: Among 131,016 patients with infection and organ failure, mortality increased from 
10.6% for the respiratory rate criterion to 15.8% for the heart rate criterion (P<0.01); from 
10.1% for the high leukocyte count criterion to 20.0% for a low count and from 10.1% for a 
high temperature to 14.4% for a low temperature criterion. With any two SIRS criteria, 
hospital mortality varied from 11.5% to 30.8% depending on the combination of criteria. This 
difference remained unchanged after adjustments and was consistent over time. 
Conclusions: Different individual and combinations of SIRS criteria were associated with 
marked differences in hospital mortality. These differences remained unchanged after 
adjustment and over time and imply that individual SIRS criteria are not equivalent or 
interchangeable. 
 
Funding: No external funding. 
 















Key words: Sepsis, systemic inflammatory response syndrome, intensive care, critical illness, 
















Severe sepsis is a major cause of intensive care unit admission and mortality [1, 2]. Until 
recently, sepsis, severe sepsis and septic shock were defined by the consensus statement of 
the American College of Chest Physicians and the American Society of Critical Care Medicine 
in 1992 [3]. Since then, randomized controlled trials in sepsis have used such criteria for 
patient enrolment [4-11], including the need for at least two Systemic Inflammatory 
Response Syndrome (SIRS) criteria. The sensitivity of this approach in identifying intensive 
care unit patients with severe sepsis, however, was recently challenged by a large 
observational study, which found that one in eight septic patients did not have two or more 
SIRS criteria [12]. This observation and well documented concerns about specificity [13, 14] 
have recently led the joint American Society of Critical Care Medicine (SCCM) and European 
Society of Intensive Care Medicine (ESICM) Task Force on Sepsis to remove the SIRS criteria 
from the definition of sepsis [15]. Despite such decision, however, strong support remains 
for the continued use of SIRS criteria [16, 17], and their assessment continues to be reported 
as part of the diagnosis of sepsis [18], thus fuelling a continuing controversy about the 
validity and clinical usefulness of such criteria. 
Such strong support for the continued application of the SIRS criteria as originally described 
logically implies that each SIRS criterion must be considered equivalent and interchangeable 
with another. Thus, for example, patients with an elevated respiratory rate and fever are, by 
definition, taken to be broadly equivalent in terms of pathophysiological state and mortality 
risk to patients with a low white cell count and tachycardia (both groups would have 2 SIRS 















pathophysiological and clinical validity of the SIRS criteria and their continued use, for 
example, to assist with patient enrolment into sepsis trials. However, the robustness of this 
assumption for both different individual criteria and different combinations of criteria has 
never been tested. 
We hypothesized that individual SIRS criteria have markedly different associations with 
hospital mortality in intensive care unit patients with infection and organ failure and that 
various combinations of two or three SIRS criteria identify septic intensive care unit patients 
with markedly different mortality risks. Moreover, we hypothesized that the two SIRS 
criteria (white cell count and temperature) that carry a high or a low value SIRS inclusion 
trigger have markedly different associations with mortality depending on their fulfilment on 
the basis of a high vs. low value. Finally, we hypothesized that such differential associations 
have held steady over more than a decade despite major changes in hospital mortality 




We conducted a retrospective study of intensive care unit (ICU) patients from January 1, 
2000, to December 31, 2015, using data from the Australia and New Zealand Intensive Care 
Society (ANZICS) Adult Patient Database (APD), run by the ANZICS Centre for Outcome and 
Resource Evaluation [19]. Data were gathered by means of clinical registry surveillance by 
data collectors for quality-assurance and benchmarking as previously described [12, 20] and 















approved by the Alfred Hospital Human Research Ethics Committee, Melbourne, Australia, 
with a waiver of informed consent. 
 
Definitions 
We used the consensus definition of the American College of Chest Physicians-Society of 
Critical Care Medicine to identify patients with sepsis, severe sepsis, and septic shock [3]. 
First, infection-related diagnoses at intensive care unit admission and confirmed at ICU 
discharge were defined according to the Acute Physiology and Chronic Health Evaluation 
(APACHE) III to infer the presence of suspected or proven infection (Supplementary 
Appendix) [12]. We then defined organ failure in the first 24 hours after ICU admission using 
the Sequential Organ Failure Assessment (SOFA) score system [12, 20]. 
We applied the consensus SIRS criteria to data analyses, except for analyses where the 
criteria with dual nature (high/low) were considered as separate criteria. All patients with 
infection and organ failure fulfilling at least one SIRS criterion were included into the study.  
 
Statistical analysis 
Data are presented as percentages (number), means (standard deviation, SD), medians 
(interquartile range, IQR) or proportion (95% confidence interval, CI). Chi-square tests for 
equal proportion, student’s t-tests or Wilcoxon Rank Sum test were used to test differences. 
No assumptions were made for missing or unavailable data, with multivariable analysis 
performed on patients with complete data only. Where data were missing, the available the 















To determine the nature of the relationship between SIRS criteria and hospital mortality, 
logistic regression models were fitted adjusting for year of admission and patient severity 
with patients nested within site and site treated as a random effect. To estimate patient 
severity independent of SIRS components, each patient’s predicted risk of death was 
calculated with SIRS components removed in accordance with the Australian and New 
Zealand calibrated Risk of Death model (ANZROD)[21], which controls the case-mix for 
admission diagnosis and which has been shown to consistently perform better than APACHE 
III in ANZ [22, 23]. To ascertain if the change in outcome over time differed between SIRS 
categories, an interaction term between severe sepsis and year of admission was fitted with 
year of admission treated first as a categorical variable and then as a continuous variable 
following verification of linearity. For increased interpretability, when analysis were 
performed to differentiate between extremes, patients who met both high and low criteria 
for Temperature (n=5496) and White Cell Count (n=954) were removed from the analysis. All 
logistic regression results have been reported using Odds Ratios (95%CI). All data were 
analyzed by SAS Version 9.4 (SAS Institute Inc., Cary, NC, USA). A two-sided P –value of 0.01 




A total of 1,557,844 patients above 16 years old were treated during the assessment period 
in the 179 study ICUs. The exclusion process of patients is presented in Table E1. The final 















least one SIRS criterion. The baseline characteristics of study patients stratified by 
survivorship are presented in Table 1. Overall, septic shock was present in two thirds of 
patients, mechanical ventilation was applied to approximately half and renal failure was 
present in approximately one in every five patients. The median number of SIRS criteria on 
day one was three and survivors more often had only one or two SIRS criteria (p<0.001). The 
annual incidence of SIRS criteria per intensive care unit admission is presented in Figure E1. 
 
Mortality according to SIRS criteria 
In patients fulfilling any (but only one) of the four SIRS criteria, hospital mortality rate 
increased from 10.6% with respiratory rate to 11.3% with any (low and high combined) 
white cell count to 13.5% with any (low and high combined) temperature to 15.8% with 
heart rate criteria fulfilment (Figure 1, Table E2). The absolute and adjusted mortalities with 
any combinations of two and three SIRS criteria are also presented in Figure 1 and Table E2.  
 
Mortality in patients with high or low white cell count and temperature criteria 
Patients with a low white cell count had a hospital mortality rate of 20.0% vs. 10.4% in 
patients with high white cell count patients (Figure 2, Table E3). The respective numbers for 
high and low temperature were 10.1% and 14.4%. After adjustments, the highest odds for 
hospital mortality were 1.97 (1.26-3.06) for low white cell count with high temperature as a 
referent (Figure 2, Table E3). 
In patients fulfilling only one SIRS criterion, unadjusted hospital mortality increased from 
10.1% for high temperature to 14.4% for low temperature, to 15.8% for tachycardia and to 















there were only small changes in the order of increasing hospital mortality, with a low white 
cell count carrying highest odds for hospital mortality of 1.94 (1.25-3.03) (Figure 3, Table E4). 
 
Mortality according to various combinations of SIRS criteria 
Patients fulfilling only two SIRS criteria had the lowest hospital mortality if the combination 
of criteria were respiratory rate and high temperature (11.5%). The highest hospital 
mortality was seen for the combination of low white cell count and fast heart rate (30.8%) 
(Figure 3, Table E4). When adjusted for APACHE score, there were only minor changes in 
hospital mortality risk, the highest OR being 2.03 (1.56-2.64) for heart rate and low white 
cell count (Figure 3, Table E4). Patients fulfilling only the low white cell count criterion (1 
SIRS criterion only) had hospital mortality rate of 20.0%. This mortality rate was higher than 
the mortality rate in 88% of patients meeting any two SIRS criteria (Figure 3, Table E4). 
 
Secular Changes in mortality for SIRS criteria 
During a decade and a half, hospital mortality in patients fulfilling different individual SIRS 
criteria decreased over time for each criterion in a similar way (Figure 4). The adjusted 
annual odds (95% confidence interval) for decline in mortality for separate SIRS criteria were 
0.95 (0.93-0.98) for heart rate, 0.96 (0.93-0.99) for temperature, 0.93 (0.91-0.96) for white 
cell count, and 0.91 (0.88-0.94) for respiratory rate. 
The absolute decrease in hospital mortality from 2000 to 2015 was from 53.6% to 28.0% in 
patients with low white cell count criterion and from 34.1% to 16.6% in patients with high 
white cell count criterion (Figure 5). The adjusted annual odds ratios (95% CI) were 0.94 















There was a significant difference in the adjusted decline in mortality between low and high 
white cell count criteria (p<0.001 for interaction) due to a greater decrease in low white cell 
count patients. Similar changes occurred in patients with the low vs. high temperature 




We performed a multicenter observational study of ICU patients with sepsis to assess the 
prognostic equivalence and interchangeability of SIRS criteria in terms of their individual, 
combination-related, and high vs. low value association with hospital mortality. We found 
that, in a cohort of more than 130,000 sepsis patients, separate individual SIRS criteria had 
different associations with hospital mortality. Moreover, we found that separate 
combinations of SIRS criteria and separate low vs. high values for the white cell count and 
temperature SIRS criteria all had markedly different associations with hospital mortality. 
Finally, we found that these difference held steady over 15 years of observation despite a 
progressive decline in associated hospital mortality. 
 
Relationship with previous studies 
To our knowledge, this is the first study to assess whether individual SIRS criteria have 
different associations with mortality in ICU patients with infection and organ failure; 
whether various combinations of two or three SIRS criteria also identify septic patients with 
different mortality risks, and, finally, whether individual SIRS criteria (white cell count and 















they are fulfilled because of a high (leukocytosis and fever) or low value (leukopenia and 
hypothermia).  
 
Previous studies of SIRS criteria have focused on the specificity or sensitivity of SIRS criteria 
in identifying patients with sepsis [12-14, 24]. Such studies while addressing an important 
aspect of their validity, did not address the key issue of equivalence or interchangeability 
which is implied when, for example, any two criteria are required to define the presence of 
SIRS. Such equivalence or interchangeability has been implied and assumed since the 1992 
definition of sepsis but has never been tested. This is despite its importance in terms of 
defining the biological credibility, clinical robustness, pathophysiological plausibility and face 
validity of the SIRS criteria. 
 
Implications of study findings 
Our findings imply that individual SIRS criteria do not describe pathophysiological 
phenotypes with equivalent risk of death and, logically, cannot be used interchangeably to 
describe similar risk states. Moreover, they imply that such concerns also apply to 
combinations of SIRS criteria or even to each criterion with dual fulfilment where low-value 
based presence carries a markedly different risk compared to high-value based presence. 
Finally, by showing that such differences in risk have held steady over a decade and a half 
despite marked changes in overall mortality, our findings suggest that such differential risk 
may represent the epidemiological expression of abiding clinical phenotypes and underlying 















The original purpose of SIRS criteria was to define the presence of sepsis [3]. According to 
the current sepsis definition, Sepsis 3, the significance of disturbance in homeostasis in 
infection was defined by a mortality of >10% [15]. Accordingly, we studied the significance of 
SIRS criteria not in defining sepsis but defining the prognostic significance of various SIRS 
criteria (or their subcomponents) in patients with infection and organ failure 
 
Strengths and Limitations 
This study has several strengths. It used data from a large cohort of >130,000 septic patients, 
in two countries over a decade and a half. It is the first study to assess the concept of 
equivalence of risk for SIRS criteria. It assessed such equivalence for individual criteria, for 
combination of criteria and for criteria with dual fulfilment, thus providing a full assessment 
of the concept. Moreover, it assessed such differential risk over 15 years to establish its 
robustness despite secular mortality trends. Finally, its findings have important implications 
in relation to the continued use of two SIRS criteria in clinical practice and trial medicine. 
Our study also carries some limitations. Our observations pertain to the first 24 hours after 
ICU admission only. Thus, we cannot comment on the equivalence of SIRS criteria prior to 
ICU admission or after the first 24 hours. Similarly, the diagnosis of severe sepsis/septic 
shock only applied to patient characteristic during the first 24 hours in ICU. Thus, patients 
who developed sepsis later while in the ICU were not part of this analysis. The accuracy of 
sepsis diagnosis could not be confirmed by independent adjudication. However, data were 
collected by trained collectors and we used physiological coding for SIRS and organ failure, 
which are less subject to coding artefact. Moreover, coders could not be a source of 















purpose. We also accounted for the APACHE admission diagnoses of sepsis as well as 
APACHE admission diagnoses for infection to ensure that diagnostic coding changes would 
not fail to identify all patients of interest. In addition, the diagnostic criteria for sepsis were 
kept constant throughout the study period enabling us to detect changes in the equivalence 
of criteria over time, if any existed. Despite such consideration, we acknowledge that Finally, 
we can only use mortality risk at hospital discharge to assess equivalence. Although, such 
outcome can be used as a surrogate for 30-day mortality [25], we cannot comment on 90- 
day mortality or long-term mortality. 
 
Conclusions 
In patients with sepsis, we aimed to assess the equivalence and interchangeability of 
individual, combinations, and dual-fulfilment (high vs. low) SIRS criteria in terms of hospital 
hospital mortality. We found that, in a cohort of more than 130,000 patients, separate 
individual SIRS criteria, separate combinations of SIRS criteria and separate low vs. high 
values for the white cell count and temperature criteria all had markedly different 
associations with hospital mortality. We also found that such differences held steady over 15 
years of observation. Our findings contradict the interchangeable use of different SIRS 
criteria, suggest that they may represent different pathophysiological states and challenge 
the long standing clinical basis for the use of any two SIRS criteria as equivalent. 
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Figure 1: Upper panel: Unadjusted mortality according to fulfillment of one, two or three 
Systemic Inflammatory Response Syndrome (SIRS) criteria.  
Lower panel: Adjusted mortality according to SIRS criteria. Analyses were performed using 
logistic regression adjusting for patient severity (ANZROD) and year of admission with 
patients nested within site and site treated as a random effect. 
RR Respiratory rate, WCC White cell count, Temp Temperature, HR Heart rate.  
 
Figure 2. Unadjusted mortality (upper panel) and logistic regression adjusted (severity, year 
with patients nested within sites and sites treated as a random effect) odds (lower panel) for 
mortality (95% Confidence intervals) in sepsis patients fulfilling either high or low systemic 
inflammatory response syndrome criteria for white blood cells (WCC) and temperature 
(Temp). 
 
Figure 3: Absolute and adjusted mortality in sepsis patients fulfilling various SIRS criteria 
(with WCC and temperature considered as high and low values) and various combinations of 
SIRS criteria. Analyses were performed using logistic regression adjusting for patient severity 
(ANZROD) and year of admission with patients nested within site and site treated as a 
random effect. 
TH Temperature high, TL temperature low, RR respiratory rate, WH White Cell Count high, 

















Figure 4. Unadjusted mortality during the study period according to Systemic Inflammatory 
Response Syndrome (SIRS) criteria. The P-value for interaction was 0.05. 
 
Figure 5. Upper panel: Mortality over time in sepsis patients with either high or low white 
cell count criteria. The annual odds for decline in mortality (95% confidence intervals) was 
0.94 (0.93-0.95) for low white cell count and 0.95 (0.95-0.96) for high white cell count 
(p<0.001 for interaction between high and low). 
Lower panel: Mortality over time in sepsis patients with high or low temperature criteria. 
The annual odds for decline were 0.94 (0.94-0.95) for low temperature and 0.96 (0.95-0.97) 






















Age, mean (SD) 63.4 (17.1) 61.8 (17.4) 69 (14.5) <0.0001 
Male gender, % (n) 55% (71765) 54% (55065) 57% (16700) <0.0001 
Hospital Admission Source: Home, % (n) 66% (86731) 67% (67992) 64% (18739) <0.0001 
  Other Hospital, % (n) 24% (31342) 24% (24178) 25% (7164) 0.007 
  Chronic Care, % (n) 2% (2556) 2% (1819) 3% (737) <0.0001 
  Other ICU, % (n) 2% (2410) 2% (1762) 2% (648) <0.0001 
  Unknown, % (n) 6% (7977) 6% (6042) 7% (1935) <0.0001 
Apache III score, Mean (SD) 70.7 (29.3) 63.45 (24.39) 95.88 (31.11) <0.0001 
Apache III Risk of Death, Median (IQR) 0.21 [0.09-0.45] 0.16 [0.07-0.33] 0.53 [0.3-0.76] <0.0001 
Australian and New Zealand Risk of Death, Median 
(IQR) 0.10 [0.03-0.26] 0.07 [0.03-0.17] 0.35 [0.15-0.62] <0.0001 
Length of stay: ICU (days), median (IQR) 3.3 [1.7-6.9] 3.3 [1.7-6.7] 3.3 [1.3-8.0] <0.0001 
  Hospital (days), Median (IQR) 12.8 [6.6-24.8] 13.6 [7.5-26.2] 9.1 [3.2-20.0] <0.0001 












Septic shock, % (n) 68% (88946) 66% (67591) 73% (21355) <0.0001 
Mechanical ventilation, % (n) 50% (65478) 46% (47298) 62% (18180) <0.0001 
Acute renal failure, % (n) 18% (23819) 14% (13907) 34% (9912) <0.0001 
Total number of SIRS criteria met, median (IQR) 3 [2-4] 3 [2-4] 3 [3-4] <0.0001 
 >1 SIRS criteria, % (n) 91% (119285) 90% (91541) 95% (27744) <0.0001 
Met 0 SIRS criteria, % (n) 0% (0) 0% (0) 0% (0) 1.00 
Met 1 SIRS criteria, % (n) 9% (11731) 10% (10252) 5% (1479) <0.0001 
Met 2 SIRS criteria, % (n) 24% (31692) 26% (26112) 19% (5580) <0.0001 
Met 3 SIRS criteria, % (n) 39% (51059) 39% (39291) 40% (11768) <0.0001 
Met 4 SIRS criteria, % (n) 28% (36534) 26% (26138) 36% (10396) <0.0001 
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